Veil Jourde, advisor to MBO & Co in the CMN investment
Veil Jourde, advisor to MBO & Co in its investment in the nuclear medicine group CMN
The CMN group, the leading private structure dedicated to nuclear medicine in France, has chosen MBO & Co to accelerate its development.
MBO & Co was advised in this transaction by the law firm Veil Jourde, with:
- Laurent Jobert, partner, Vincent Ramel, counsel, and Virgile Morel, associate, on corporate and contractual matters,
- as well as by Benoît Gréteau, partner, and Charlotte Bittermann, associate, on tax matters.
Team
Press Review References:
- Global Legal Chronicle, January 19, 2022, France, “MBO & Co investit dans CMN”
- Capital Finance, January 13, 2022, deals Private equity – LBO, “MBO & Co mise sur la médecine nucléaire avec CMN”
- CFNews, January 13, 2022, deals LBO / MBO, “CMN irradie un premier fonds”
And in the databases of Fusions Acquisitions Magazine and Private Equity Magazine.
